100 Executive Women in Tech
to Watch in 2025
Lidia Fonseca
Chief Digital and Technology Officer at Pfizer
Lidia Fonseca is a seasoned healthcare executive with over 20 years of industry experience and currently leads Pfizer's digital, data, and technology initiatives. In her role, she oversees the digitization of drug discovery, clinical development, manufacturing, distribution, and commercial operations. Under her leadership, Pfizer has achieved significant automation, with over 90% of transactional processes automated across the company.
Lidia is at the forefront of leveraging artificial intelligence (AI), robotics, and advanced analytics to enhance operational efficiency and enable better decision-making. She has spearheaded the introduction of AI-powered predictive algorithms for disease suspicion, treatment optimization, and adherence. Lidia is also committed to improving patient outcomes through innovative digital health solutions, including the launch of Pfizer's Digital Companion™.
Recognized for her leadership, Lidia has received numerous awards and accolades, including being named on the Forbes CEO Next List and Forbes CIO Next List. She serves on the Board of Directors of Medtronic and the U.S.-Japan Business Council. Lidia's contributions extend beyond Pfizer, as she previously held board positions at Tegna, Inc., Gannett, Inc., and Q2 Solutions.
Lidia is at the forefront of leveraging artificial intelligence (AI), robotics, and advanced analytics to enhance operational efficiency and enable better decision-making. She has spearheaded the introduction of AI-powered predictive algorithms for disease suspicion, treatment optimization, and adherence. Lidia is also committed to improving patient outcomes through innovative digital health solutions, including the launch of Pfizer's Digital Companion™.
Recognized for her leadership, Lidia has received numerous awards and accolades, including being named on the Forbes CEO Next List and Forbes CIO Next List. She serves on the Board of Directors of Medtronic and the U.S.-Japan Business Council. Lidia's contributions extend beyond Pfizer, as she previously held board positions at Tegna, Inc., Gannett, Inc., and Q2 Solutions.
